Cart
sales@molnova.com
Sepimostat
CAS No. 103926-64-3
Sepimostat( —— )
Catalog No. M23248 CAS No. 103926-64-3
Sepimostat exhibits neuroprotective activity via NR2B N-methyl-D-aspartate receptor antagonism at the Ifenprodil-binding site of the NR2B subunit.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 222 | In Stock |
|
| 10MG | 372 | In Stock |
|
| 25MG | 623 | In Stock |
|
| 50MG | 887 | In Stock |
|
| 100MG | 1197 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSepimostat
-
NoteResearch use only, not for human use.
-
Brief DescriptionSepimostat exhibits neuroprotective activity via NR2B N-methyl-D-aspartate receptor antagonism at the Ifenprodil-binding site of the NR2B subunit.
-
DescriptionSepimostat exhibits neuroprotective activity via NR2B N-methyl-D-aspartate receptor antagonism at the Ifenprodil-binding site of the NR2B subunit. Sepimostat dimethanesulfonate inhibits the Ifenprodil binding with a Ki value of 27.7?μM.
-
In Vitro——
-
In VivoSepimostat (1 to 100 nmol/eye, intravitreal injection) exhibits significant neuroprotective effect. Animal Model:Male Sprague Dawley rats weighing 150-300?g.Dosage:Intravitreal injection.Administration:1 to 100 nmol/eye.Result:Exhibited neuroprotective effects significantly.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetiGluR
-
RecptorNR2B N-methyl-D-aspartate
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number103926-64-3
-
Formula Weight373.41
-
Molecular FormulaC21H19N5O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:6.25 mg/mL?(16.74 mM;?Need ultrasonic)
-
SMILESC1CN=C(N1)NC2=CC=C(C=C2)C(=O)OC3=CC4=C(C=C3)C=C(C=C4)C(=N)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Masahiro Fuwa, et al. Nafamostat and Sepimostat Identified as Novel Neuroprotective Agents via NR2B N-methyl-D-aspartate Receptor Antagonism Using a Rat Retinal Excitotoxicity Model. Sci Rep. 2019 Dec 31;9(1):20409.
molnova catalog
related products
-
UK-240455
UK-240455 is a potent and selective N-methyl-D-aspartic acid (NMDA) glycine receptor antagonist with neuroprotective effects and improvements in motor function in Parkinson's disease models, making it a potential candidate for Parkinson's disease treatment.
-
NS-1209
A selective, water-soluble, in vivo long-lasting AMPA antagonist with Ki of 43 nM; display selectivity for the [3H] AMPA over the [3H]kainate- (IC50=81 uM), [3H]CGS19755, and [3H]glycine-binding sites (IC50 > 30 uM) in rat cortical membranes.
-
SYM 2081
SYM 2081 is a specific kainate receptor agonist with an IC50 value of 35 nM for [3H]-kainate binding. SYM 2081 depolarizes the muscle and reduces the EPSP amplitude.
